Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
COVID-19 (novel coronavirus), 2023 (12)
March, 2023 (2)
- Engaging with communities to encourage adoption of a harm reduction approach to COVID-19.
Hellard M, Motorniak D, Tse WC, Saich F, Stoové M
Aust N Z J Public Health. 2023 Mar; 47(2):100022 - The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia.
Rathnayake K, Agius PA, Ward B, Hickman M, Maher L, Stoové M, Doyle JS, Hellard M, Wilkinson A, Quinn B, Crawford S, Sutton K, Dietze P
Addiction. 2023 Mar; Epub ahead of print
February, 2023 (3)
- Recruiting and retaining community-based participants in a COVID-19 longitudinal cohort and social networks study: lessons from Victoria, Australia.
Nguyen T, Thomas AJ, Kerr P, Stewart AC, Wilkinson AL, Nguyen L, Altermatt A, Young K, Heath K, Bowring A, Fletcher-Lartey S, Lusher D, Hill S, Pedrana A, Stoové M, Gibney K, Hellard M
BMC Med Res Methodol. 2023 Feb; 23(1):54 - COVID-19 vaccine attitudes and facilitators among people in Australia who inject drugs.
Price O, Maher L, Dietze PM, Bruno R, Crawford S, Sutherland R, Salom C, Dore GJ, Peacock A
Drug Alcohol Rev. 2023 Feb; Epub ahead of print - Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions.
Price O, Man N, Sutherland R, Bruno R, Dietze P, Salom C, Agramunt S, Grigg J, Degenhardt L, Peacock A.
Int J Drug Policy. 2023 Feb; 113:103976
January, 2023 (7)
- Inclusion of Cultural and Linguistic Diversity in COVID-19 Public Health Research: Research Design Adaptations to Seek Different Perspectives in Victoria, Australia.
Gibbs L, Thomas AJ, Coelho A, Al-Qassas A, Block K, Meagher N, Eisa L, Fletcher-Lartey S, Ke T, Kerr P, Kwong EJL, MacDougall C, Malith D, Marinkovic Chavez K, Osborne D, Price DJ, Shearer F, Stoové M, Young K, Zhang Y, Gibney KB, Hellard M
Int J Environ Res Public Health. 2023 Jan; 20(3):2320 - Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecasts.
Houdroge F, Palmer A, Delport D, Walsh T, Kelly SL, Hainsworth SW, Abeysuriya R, Stuart RM, Kerr CC, Coplan P, Wilson DP, Scott N
Sci Rep. 2023 Jan; 13(1):1398 - Estimating the proportion of Victorians infected with COVID-19 during the Omicron BA.1 epidemic wave of January 2022 in Australia.
Altermatt A, Heath K, Saich F, Wilkinson AL, Scott N, Sacks-Davis R, Young K, Stoové M, Gibney KB, Hellard M
Aust N Z J Public Health. 2023 Jan; 47(1):100007 - COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).
Kahn AL, Steffen CA, Henaff L, MacDonald NE, Morgan C, Faden R, Olayinka F, Desai S
Vaccine. 2023 Jan; 41(3):676-683 - Returning to the nest: Emerging adults living with parents during the COVID-19 pandemic.
Prattley J, Evans-Whipp T, O'Donnell K, Wong C, Quinn B, Rowland B
Aust J Soc Issues. 2023 Jan; Epub ahead of print - The United Kingdom and the Netherlands maternity care responses to COVID-19: A comparative study.
van den Berg LMM, Balaam MC, Nowland R, Moncrief G, Topalidou A, Thompson S, Thomson G, de Jonge A, Downe S; ASPIRE-COVID19 Research Team (Including Caroline Homer)
Women Birth. 2023 Jan; 36(1):127-135 - The second COVID-19 mRNA vaccine dose enhances the capacity of Spike RBD-specific memory B cells to bind Omicron BA.2.
Hartley GE, Edwards ESJ, Varese N, Boo I, Aui PM, Bornheimer SJ, Hogarth PM, Drummer HE, O'Hehir RE, van Zelm MC
Allergy. 2023 Jan; 78(3):855-858
Year
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
- 1997
- 1996
- 1995
- 1994
- 1993
- 1992
- 1991
- 1990
- 1989
- 1988
- 1987
- 1982
- 1981
- 1955
Program
- All
- Executive (0)
- Healthy Mothers, Healthy Babies (HMHB) (0)
- Towards Eliminating HIV (7)
- Strategic Funding & Partnerships Executive Team (0)
- Disease Elimination (76)
- Maternal, Child and Adolescent Health (56)
- Philanthropy and Supporter Engagement (0)
- Health Security and Pandemic Preparedness (32)
- Eliminate Malaria (7)
- Eliminate Tuberculosis (TB) (6)
- Finance (0)
- Healthy Ageing (1)
- Human Resources (0)
- Burnet Honorary Research Fellows (1)
- Research Support and Facilities (0)
- Harm Reduction (27)
- Information Technology (0)
- Burnet Vaccine Initiative (0)
- Laboratory Services (0)
- Eliminate Viral Hepatitis (9)
- Education & Training (0)
- Infectious Diseases Elimination (2)
- Support Services Group (0)
- Project Management and Quality Assurance Office (0)
- Marketing and Communications (0)
- International Operations (0)
- Commercialisation, Innovation and Industry Partnerships (0)
Discipline
- All
- Life Sciences (0)
- Public Health (0)
- International Development (0)
Research Theme
- All
- HIV and AIDS (8)
- Sexually Transmitted Infections (STIs) (3)
- Maternal and Child Health (20)
- Malaria (7)
- Immune Disease and Cancer (1)
- Hepatitis B (4)
- Hepatitis C (8)
- Global infectious disease threats (1)
- Injecting Drug Use (16)
- Alcohol and Other Drugs (18)
- Tuberculosis (TB) (6)
- Young People's Health (2)
- Justice Health (4)
- Sexual and Reproductive Health (4)
- Infectious Disease Modelling (4)
- LGBTQIA+ (1)
- Global Adolescent Health (2)
- COVID-19 (novel coronavirus) (12)
